Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis.

Queiro R, Cañete JD, Montilla C, Abad MA, Montoro M, Gómez S, Cábez A; MAAPS Study Group.

J Rheumatol. 2019 Jul;46(7):710-715. doi: 10.3899/jrheum.180460. Epub 2019 Feb 1.

PMID:
30709957
2.

Drug immunogenicity in patients with inflammatory arthritis and secondary failure to tumour necrosis factor inhibitor therapies: the REASON study.

Balsa A, Sanmarti R, Rosas J, Martin V, Cabez A, Gómez S, Montoro M.

Rheumatology (Oxford). 2018 Apr 1;57(4):688-693. doi: 10.1093/rheumatology/kex474.

PMID:
29365183
3.

Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study.

Queiro R, Cañete JD, Montilla C, Abad M, Montoro M, Gómez S, Cábez A; MAAPS study group.

Arthritis Res Ther. 2017 Mar 29;19(1):72. doi: 10.1186/s13075-017-1277-1.

4.

Dose-response relationship of luteinizing hormone to luteinizing hormone--releasing hormone in man.

Kastin AJ, Schally AV, Gual C, Midgley AR Jr, Miller MC 3rd, Cabez A.

J Clin Invest. 1971 Jul;50(7):1551-3.

Supplemental Content

Support Center